Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Congressional Testimony

Congressional Testimony

                        Congressional Testimony 2018 - 2019
          Congressional Testimony  2017
          Congressional Testimony 2016 Home
          News & Events
          Congressional Testimony
          Reauthorization of the Animal Drug User Fee Programs - 03/30/2023Congressional Testimony Testimony
    Event Title
              Reauthorization of the Animal Drug User Fee Programs


                  March 30, 2023

  

    
  Share
    Post
    Linkedin

    Email
    PrintTestimony of 
                    
          Tracey H. Forfa, J.D., M. Div.  Director - Center for Veterinary Medicine   

 




INTRODUCTION

Good morning, Chairman Guthrie, Ranking Member Eshoo, and Members of the Subcommittee. I am Tracey Forfa, Director of the Center for Veterinary Medicine (CVM) at the Food and Drug Administration (FDA or the Agency), under the Department of Health and Human Services (HHS). I have also had the honor of serving as the Deputy Director of CVM for the last 15 years. I am grateful for this opportunity to discuss FDA’s proposals for reauthorization of the Animal Drug User Fee Act and the Animal Generic Drug User Fee Act for an additional five years (ADUFA V and AGDUFA IV).

With the enactment of ADUFA in 2003 and AGDUFA in 2008, Congress brought CVM the needed infusion of funds to resolve a long-standing backlog of animal drug applications and created efficiencies and predictability in the review process. Congress also created an opportunity – at five-year intervals – for CVM and industry to assess these user fee programs with the intention of advancing the animal drug review process to accommodate new developments and address new challenges. These are highly successful programs that facilitate the availability of approved products for food-producing and other animals, and foster a reliable review framework to accommodate drug development. Both programs help FDA maintain a stable scientific and technical workforce, improve timely communications with drug sponsors, and achieve other efficiencies such as reduced review times in the drug application review process while maintaining science-based regulatory standards for animal drug safety and efficacy.

Click for full version of testimony

                                                                                  Content current as of:
      03/30/2023More Congressional
      Testimonies

        
        Congressional Testimony

          
                        Congressional Testimony 2018 - 2019
          Congressional Testimony  2017
          Congressional Testimony 2016
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop